Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dietary starch and other polysaccharides are complex carbohydrates that serve as the primary energy source for humans, consisting of glucose polymers like amylose and amylopectin (StatPearls, 2023). These molecules are not therapeutic targets themselves but are the substrates for digestive enzymes such as alpha-amylase and alpha-glucosidase (NIH, 2022). In the management of metabolic disorders like type 2 diabetes, the rate of starch digestion is pharmacologically modulated to prevent rapid spikes in blood glucose levels (PubMed, 2021). Drugs like acarbose and miglitol target the enzymes responsible for hydrolyzing these polysaccharides, effectively slowing glucose absorption and improving glycemic control (PubChem, 2024). Additionally, non-digestible polysaccharides, known as dietary fiber, play a crucial role in gut health and the modulation of the microbiome (Wikipedia, 2024).
Inhibition of alpha-amylase and alpha-glucosidase enzymes to delay the breakdown of complex carbohydrates into absorbable monosaccharides (StatPearls, 2023).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dietary starch and other polysaccharides.